List of Figures
Figure 1-1: US - Number of HIV Cases (Million), 2012, 2014 & 2018
Figure 1-2: US - Estimated Number of HIV Cases (Million), 2020, 2025 & 2030
Figure 1-3: US - Number of Newly Diagnosed HIV Cases & Deaths, 2018
Figure 1-4: US - Estimated Number of Newly Diagnosed HIV Cases, 2018, 2020 & 2025
Figure 1-5: US - Estimated Number of HIV Deaths, 2018, 2020 & 2025
Figure 1-6: US - HIV Incidence Rate (Per 100’000), 2014, 2018 & 2020
Figure 1-7: US - HIV Incidence Rate by Age Group (Per 100’000), 2018
Figure 1-8: US - HIV Incidence Rate by Race (Per 100’000), 2018
Figure 1-9: US - HIV Incidence Rate by Gender (Per 100’000), 2018
Figure 1-10: US - HIV Cases by Mode of Transmission (%), 2018
Figure 1-11: US - Percentage of HIV Patients by Nature of Treatment (%), 2018
Figure 2-1: Global - HIV Drug Market Opportunity (US$ Billion), 2020 - 2026
Figure 2-2: Global - HIV Drug Market Size by Region (US$ Billion), 2020
Figure 2-3: Global - HIV Drug Market Size by Region (US$ Billion), 2020
Figure 2-4: North America - HIV Drug Market Size US v/s Others (US$ Billion), 2020
Figure 2-5: US - HIV Drug Market Opportunity (US$ Billion), 2020 - 2026
Figure 2-6: US - Number of HIV Infection Drug Clinical Pipeline by Phase, 2021 - 2026
Figure 2-7: US - Number of HIV Infection Drugs in Clinical Pipeline by Drug Class, 2021 - 2026
Figure 2-8: US - Number of HIV Infection Drugs in Clinical Pipeline by Organization, 2021 - 2026
Figure 2-9: US - Number of HIV Infection Drugs in Clinical Pipeline by Patient Segment, 2021 - 2026
Figure 3-1: Ziagen - FDA Approval & First Generic Approval Year
Figure 3-2: Ziagen Oral Solution - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 3-3: Ziagen Tablet - Price for 60 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-4: Generic Abacavir Oral Solution - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 3-5: Generic Abacavir Tablet - Price for 60 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-6: Ziagen - Daily Treatment Cost by Dosage Form (US$)
Figure 3-7: Ziagen - Pediatric Dosage form by Weight (mg/day)
Figure 3-8: Emtriva - FDA Approval Year by Dosage Form
Figure 3-9: US - Emtriva Patent Issue & Expiration Year
Figure 3-10: Emtriva Oral Solution - Price for 170ml Supply & Price Per ml (US$), February’2021
Figure 3-11: Emtriva Tablet - Price for 30 Capsules & Price Per Unit Capsule (US$), February’2021
Figure 3-12: Emtriva - Daily Dose by Dosage Form (mg)
Figure 3-13: Emtriva: Daily Treatment Cost by Dosage Form (US$), February’2021
Figure 3-14: Epivir: FDA Approval Year by Dosage Form
Figure 3-15: Epivir: First Generic Approval Year by Dosage Form
Figure 3-16: Epivir Oral Solution - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 3-17: Epivir 150mg Tablet - Price for 60 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-18: Epivir 300mg Tablet - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-19: Generic Lamivudine Oral Solution - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 3-20: Generic Lamivudine 150mg Tablet - Price for 60 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-21: Generic Lamivudine 150mg Tablet - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-22: Generic Lamivudine 150mg Tablet - Price for 50 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-23: Generic Lamivudine 300mg Tablet - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 3-24: Epivir: Daily Treatment Cost by Dosage Form (US$), February’2021
Figure 3-25: Epivir - Pediatric Dosage form by Weight (mg/day)
Figure 3-26: Viread - FDA Approval Year by Dosage Form
Figure 3-27: Viread - First Generic Approval Year by Dosage Form
Figure 3-28: Viread Oral Powder - Price for 60 gm Supply & Price Per gm (US$), Februray’2021
Figure 3-29: Viread 300 mg Tablet - Price for 30 Tablets & Price Per Unit Tablet (US$), Februray’2021
Figure 3-30: Viread Tablet - Price for 30 Tablets of 150,200 & 250mg Dose & Price Per Unit Tablet (US$), Februray’2021
Figure 3-31: Generic Viread 300 mg Tablet - Average Price for 28 Tablets & Price Per Unit Tablet (US$), Februray’2021
Figure 3-32: Generic Viread 300 mg Tablet - Average Price for 30 Tablets & Price per Unit Tablet (US$), Februray’2021
Figure 3-33: Generic Viread 300 mg Tablet - Average Price for 60 Tablets & Price Per Unit Tablet (US$), Februray’2021
Figure 3-34: Generic Viread 300 mg Tablet - Average Price for 90 Tablets & Price Per Unit Tablet (US$), Februray’2021
Figure 3-35: Generic Viread 300 mg Tablet - Average Price for 180 Tablets & Price Per Unit Tablet (US$), Februray’2021
Figure 3-36: Viread Tablet - Pediatric Dose by Weight (mg/day)
Figure 3-37: Viread Oral Powder - Pediatric Dosage form by Weight (mg/day)
Figure 3-38: Viread - Daily Treatment Cost by Dosage Form (US$), February’2021
Figure 3-39: Global - Viread Annual Sales Value (US$ Million), 2017 - 2020
Figure 3-40: US - Viread Annual Sales Value (US$ Million), 2017 - 2020
Figure 3-41: Global - Viread Annual Sales Value by Region (US$ Million), 2020
Figure 3-42: Global - Viread Annual Sales Value by Region (%), 2020
Figure 3-43: Global - Viread Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 3-44: US - Viread Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 3-45: Retrovir - FDA Approval Year by Dosage Form
Figure 3-46: Retrovir - First Generic Approval Year by Dosage Form
Figure 3-47: Retrovir Intravenous Solution - Price for 100 ml Supply & Price Per ml (US$), February’2021
Figure 3-48: Retrovir Capsule - Price for 100 Capsules & Price Per Unit Capsule (US$), February’2021
Figure 3-49: Retrovir Syrup - Price for 240ml & Price Per ml (US$), February’2021
Figure 3-50: Generic Zidovudine Tablet - Price for 60 Tablets Supply & Price Per Unit Tablet (US$), February’2021
Figure 3-51: Generic Zidovudine Capsule - Price for 100 Capsules & Price Per Unit Capsule (US$), February’2021
Figure 3-52: Generic Zidovudine Syrup - Price for 240ml & Price Per ml (US$), February’2021
Figure 3-53: Retrovir Capsule - Daily, Monthly & Annual Treatment Cost (US$), February’2021
Figure 3-54: Retrovir - Oral Pediatric Dosage form by Weight (mg/Kg/day)
Figure 3-55: Zerit - FDA & First Generic Approval Year
Figure 3-56: Zerit - FDA Approval Year by Dosage Forms
Figure 3-57: Zerit - Price for 60 Capsule Supply & Price Per Unit Capsule of 15mg Dose (US$), February’2021
Figure 3-58: Zerit - Price for 60 Capsule Supply & Price Per Unit Capsule of 20mg Dose (US$), February’2021
Figure 3-59: Zerit - Price for 60 Capsule Supply & Price Per Unit Capsule of 30mg Dose (US$), February’2021
Figure 3-60: Zerit - Price for 60 Capsules & Price Per Unit Capsule (US$), February’2021
Figure 3-61: Generic Stavudine - Price for 60 Capsules of Various Dose Regimens (US$), February’2021
Figure 3-62: Zerit - Daily Adult Dose by Weight (mg)
Figure 3-63: Zerit - Minimum & Maximum Daily Treatment Cost (US$), February’2021
Figure 3-64: Zerit - Pediatric Dose by Age (mg/kg Twice Daily)
Figure 3-65: Videx - FDA Approval Year by Dosage Form
Figure 3-66: Videx Oral Powder for Reconstitution - Price for 200ml Supply & Price Per ml (US$), February’2021
Figure 3-67: Videx EC - Price for 30 Capsule Supply & Price Per Unit Capsule (US$), February’2021
Figure 3-68: Generic Videx EC - Price for 30 Capsule Supply & Price Per Unit Capsule (US$), February’2021
Figure 3-69: Videx - Daily Adult Dose by Weight (mg)
Figure 3-70: Videx - Minimum & Maximum Daily Treatment Cost (US$), February’2021
Figure 3-71: Videx - Pediatric Dose by Age (mg/m2 Daily)
Figure 3-72: Videx - Adult Dose by Weight (mg)
Figure 4-1: Pifeltro - FDA Approval Year by Type of Therapy
Figure 4-2: US - Pifeltro Patent Issue & Expiration Year
Figure 4-3: Pifeltro - Price for 30 Capsules & Price Per Unit Capsule (US$), February’2021
Figure 4-4: Pifeltro - Recommended Dose by Type of Therapy (mg/day)
Figure 4-5: Sustiva - FDA Approval Year by Dosage Form
Figure 4-6: Sustiva - First Generic Approval Year by Dosage Form
Figure 4-7: Sustiva Capsules - Price for 30 Capsule Supply & Price Per Unit Capsule of 50mg Dose (US$), February’2021
Figure 4-8: Sustiva Capsules - Price for 90 Capsule Supply & Price Per Unit Capsule of 200mg Dose (US$), February’2021
Figure 4-9: Sustiva Tablet - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 4-10: Generic Efavirenz Capsules - Price for 30 Capsule Supply & Price Per Unit Capsule of 50mg Dose (US$), February’2021
Figure 4-11: Generic Efavirenz Capsules - Price for 90 Capsule Supply & Price Per Unit Capsule of 200mg Dose (US$), February’2021
Figure 4-12: Generic Efavirenz Tablet - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 4-13: Sustiva - Recommended Adult Dose by Type of Therapy (mg/day), February’2021
Figure 4-14: Sustiva - Recommended Pediatric Dose by Weight (mg/day), February’2021
Figure 4-15: Intelence - FDA Approval Year by Dosage Form
Figure 4-16: US - Intelence Patent Issue & Expiration Year
Figure 4-17: Intelence - Price for 120 Tablets & Price Per Unit of 25mg & 100mg Tablet (US$), February’2021
Figure 4-18: Intelence - Price for 60 Tablets & Price Per Unit of 200mg Tablet (US$), February’2021
Figure 4-19: Intelence - Daily, Monthly & Annual treatment Cost (US$), February’2021
Figure 4-20: Intelence - Recommended Pediatric Dose by Weight (mg/day), February’2021
Figure 4-21: Edurant - Jassen’s US Patent Issue & Expiration Year
Figure 4-22: Edurant - AstraZeneca’s US Patent Issue & Expiration Year
Figure 4-23: Edurant - Price for 30 Tablet Supply & Price Per Unit Tablet of 25mg (US$), February’2021
Figure 4-24: Edurant - Daily Dose by Type of Therapy (mg), February’2021
Figure 4-25: Global - Edurant Annual Sales Value (US$ Million), 2016 - 2020
Figure 4-26: Global - Edurant Annual Sales Value (US$ Million), 2016 - 2020
Figure 4-27: Global - Edurant Annual Sales Value by Region (US$ Million), 2020
Figure 4-28: Global - Edurant Annual Sales Value by Region (%), 2020
Figure 4-29: Global - Edurant Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 4-30: US - Edurant Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 4-31: Viramune - FDA Approval Year by Dosage Form
Figure 4-32: Viramune - First Generic Approval by Dosage Form
Figure 4-33: Viramune Suspension - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 4-34: Viramune Tablet 200mg - Price for 60 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 4-35: Viramune XR Tablet 400mg - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 4-36: Generic Nevirapine Suspension - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 4-37: Generic Nevirapine Tablet 200mg - Price for 60 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 4-38: Generic Tablet 400mg - Price for 30 Tablets & Price Per Unit Tablet (US$), February’2021
Figure 4-39: Viramune - Oral Dose by Treatment Phase (mg/day), February’2021
Figure 4-40: Viramune - Recommended Pediatric Dose by Surface Area (mg/day), February’2021
Figure 5-1: Reyataz - FDA approval Year by Dosage Form
Figure 5-2: Reyataz Capsules - Price for 60 Capsule & Price Per Unit Capsule of 150 to 200mg (US$), February’2021
Figure 5-3: Reyataz Capsules - Price for 30 Capsule & Price Per Unit Capsule of 300mg (US$), February’2021
Figure 5-4: Reyataz Powder - Price for 30 Supply & Price Per Unit Oral Powder (US$), February’2021
Figure 5-5: Atazanavir Capsules - Price for 60 Capsule & Price Per Unit Capsule of 150 to 200mg (US$), February’2021
Figure 5-6: Atazanavir Capsules - Price for 30 Capsule & Price Per Unit Capsule of 300mg (US$), February’2021
Figure 5-7: Reyataz - Dose by Treatment Therapy (mg/day), February’2021
Figure 5-8: Reyataz - Recommended Pediatric Dose by Weight (mg/day), February’2021
Figure 5-9: Prezista - FDA approval Year by Dosage Form
Figure 5-10: US - Prezista Patent Issue & Expiration Year by Assignee
Figure 5-11: Prezista Suspension - Price for a Supply of 200ml & Price Per ml (US$), February’2021
Figure 5-12: Prezista Tablet - Price per unit of Various Doses (US$), February’2021
Figure 5-13: Reyataz - Dose by Type of HIV Patient (mg/day), February’2021
Figure 5-14: Reyataz - Daily Treatment Cost for Treatment Naïve Patients by Dosage Form (mg/day), February’2021
Figure 5-15: Lexiva - FDA approval Year by Dosage Form
Figure 5-16: Lexivia Suspension - Price for a Supply of 225ml & Price Per ml (US$), February’2021
Figure 5-17: Lexivia Tablet - Price for 60 Tablet Supply & Price Per Unit (US$), February’2021
Figure 5-18: Generic Fosamprenavir Tablet - Price for 60 Tablet Supply & Price Per Unit (US$), February’2021
Figure 5-19: Lexivia - Dose by Treatment Therapy (mg/day), February’2021
Figure 5-20: Lexivia - Recommended Pediatric Dose by Weight (mg/Kg Twice daily), February’2021
Figure 5-21: Norvir - FDA approval Year by Dosage Form
Figure 5-22: US - Norvir Patent Issue & Expiration Year
Figure 5-23: Norvir Powder - Price for a Supply of 30 Powders & Price Per Unit (US$), February’2021
Figure 5-24: Norvir Tablet - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 5-25: Norvir Solution - Price for 240ml Supply & Price Per ml (US$), February’2021
Figure 5-26: Generic Ritonavir Tablet - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 5-27: Norvir - Daily Treatment Cost by Dosage Form (US$), February’2021
Figure 5-28: Norvir - FDA approval Year by Dosage Form
Figure 5-29: Invirase Tablet - Price for 120 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 5-30: Invirase Tablet - Daily Dose During Initial 7 days v/s After 7 Days (mg/day), February’2021
Figure 5-31: Invirase Tablet - Daily Treatment Cost During Initial Week v/s After Initial Week (mg/day), February’2021
Figure 5-32: Aptivus - FDA approval Year by Dosage Form
Figure 5-33: Aptivus - Price for 120 Capsule Supply & Price Per Unit Capsule (US$), February’2021
Figure 5-34: Aptivus Solution - Price for 95ml Supply & Price Per ml (US$), February’2021
Figure 5-35: Aptivus - Daily Treatment Cost by Dosage Form (US$), February’2021
Figure 5-36: Viracept - FDA approval Year by Dosage Form
Figure 5-37: Viracept - Price for a Supply of 300 Tablets & Price Per Unit Tablet of 250mg (US$), February’2021
Figure 5-38: Viracept - Price for a Supply of 120 Tablets & Price Per Unit Tablet of 625mg (US$), February’2021
Figure 5-39: Viracept - Daily Minimum & Maximum Dose (mg), February’2021
Figure 5-40: Viracept Tablet - Daily Minimum & Maximum Treatment Cost (US$), February’2021
Figure 5-41: Agenerase - FDA Approval & Patent Expiration Year
Figure 5-42: Agenerase - Price for 480 Capsule Supply & Price Per Unit Capsule of 50 mg (US$), February’2021
Figure 5-43: Agenerase - Recommended Dose by Type of Therapy (mg), February’2021
Figure 5-44: Crixivan - FDA approval Year by Dosage Form
Figure 5-45: Crixivan - Patent Issue & Expiration Year
Figure 5-46: Crixivan - Price for a Supply of 360 Capsules & Price Per Unit Capsules of 200mg (US$), February’2021
Figure 5-47: Crixivan - Price for a Supply of 180 Capsules & Price Per Unit Capsules of 400mg (US$), February’2021
Figure 5-48: Crixivan - Recommended Dose by Therapy Type (mg/day), February’2021
Figure 5-49: Crixivan - Average cost of Single Dose & Daily Treatment Cost (US$), February’2021
Figure 6-1: US - Fuzeon Patent Issue & Expiration Year
Figure 6-2: Fuzeon - Price for a Supply of 60 Powders & Price Per Unit of 90mg Powder (US$), February’2021
Figure 6-3: Fuzeon - Cost of Daily, Monthly & Annual Treatment (US$), February’2021
Figure 7-1: Selzentry - FDA approval Year by Dosage Form
Figure 7-2: US - Selzentry Patent Issue & Expiration Year
Figure 7-3: Selzentry Oral Liquid - Price for a Supply of 230 ml & Price Per ml of 90mg (US$), February’2021
Figure 7-4: Selzentry Tablets - Price for a Supply of 120 Tablets & Price Per Unit of 25mg & 75mg Tablet (US$), February’2021
Figure 7-5: Selzentry Tablets - Price for a Supply of 120 Tablets & Price Per Unit of 150mg & 300mg Tablet (US$), February’2021
Figure 7-6: Selzentry - Daily Dose by Combination Agent (mg), February’2021
Figure 7-7: Selzentry - Daily Pediatric Dose in Combination in Combination with Potent CYP450 3A Inhibitors by Weight (mg), February’2021
Figure 7-8: Global - Selzentry Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 7-9: US - Selzentry Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 7-10: Selzentry - Annual Sales Value by Region (US$/GBP Million), 2020
Figure 7-11: Selzentry - Annual Sales Value by Region (%), 2020
Figure 7-12: Global - Selzentry Quarterly Sales Value (US$/GBP Million), 2020
Figure 7-13: US - Selzentry Quarterly Sales Value (US$/GBP Million), 2020
Figure 8-1: Tivicay - FDA approval Year by Dosage Form
Figure 8-2: US - Tivicay Patent Issue & Expiration Year
Figure 8-3: Tivicay - Price for a Supply of 30 Tablets & Price Per Unit Tablet of Various Doses (US$), February’2021
Figure 8-4: Tivicay - Minimum & Maximum Daily Dose (mg), February’2021
Figure 8-5: Tivicay - Minimum & Maximum Daily Treatment Cost (US$), February’2021
Figure 8-6: Tivicay - Pediatric Dose by Weight of Patient (mg), February’2021
Figure 8-7: Global - Tivicay Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 8-8: Global - Tivicay Annual Sales Value by Region (US$/GBP Million), 2020
Figure 8-9: Global - Tivicay Annual Sales Value by Region (%), 2020
Figure 8-10: Global - Tivicay Quarterly Sales Value (US$/GBP Million), 2020
Figure 8-11: US - Tivicay Quarterly Sales Value (US$/GBP Million), 2020
Figure 8-12: Isentress - FDA approval Year by Dosage Form
Figure 8-13: Isentress - Istituto Di Ricerche Di Biologia Molecolare’s Patent Issue & Expiration Year
Figure 8-14: Isentress - Merck’s Patent Issue & Expiration Year
Figure 8-15: Isentress - Price for 60 Granule Supply & Price Per Unit of 100mg Granules (US$), February’2021
Figure 8-16: Isentress - Price for 60 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 8-17: Isentress - Price for a Supply of 60 Chewable Tablets & Price Per Unit Tablet of Various Doses (US$), February’2021
Figure 8-18: Isentress HD - Price for 60 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 8-19: Isentress - Recommended Dose by Patient Type (mg/day), February’2021
Figure 8-20: Global - Isentress/Isentress HD Annual Sales Value (US$ Million), 2017 - 2020
Figure 8-21: Global - Isentress Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 9-1: Trogarzo - FDA Approval & Patent Expiration Year
Figure 9-2: Trogarzo - Price for 2.66ml Supply & Price Per ml of Intravenous Solution (US$), February’2021
Figure 9-3: Trogarzo - Loading Dose v/s Maintenance Dose (mg/2 Weeks), February’2021
Figure 9-4: Trogarzo - Cost of Loading Dose v/s Maintenance Dose (US$), February’2021
Figure 9-5: Global - Trogarzo Annual Sales (US$ Million), 2018 & 2019
Figure 9-6: US - Rukobia Patent Issue & Expiration Year
Figure 9-7: Rukobia - Price for 60 Tablets Supply & Price Per Unit of 600mg Tablet (US$), Februray’2021
Figure 9-8: Rukobia - Cost of Daily & Monthly Treatment (US$), Februray’2021
Figure 10-1: US - Tybost Patent Issue & Expiration Year
Figure 10-2: Tybost - Price for 30 Tablets Supply & Price Per Unit of 150mg (US$), February’2021
Figure 11-1: Epzicom - FDA Approval & First Generic Approval
Figure 11-2: Epzicom - Price for 30 Tablets Supply & Price per unit Tablet (US$), February’2021
Figure 11-3: Generic Abacavir/Lamivudine - Price for 30 Tablets Supply & Price Per Unit of 150mg (US$), February’2021
Figure 11-4: Epzicom - Daily, Monthly & Annual Treatment Cost (US$), February’2021
Figure 11-5: Global - Epzicom/Kivexa Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 11-6: US - Epzicom/Kivexa Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 11-7: Epzicom/Kivexa - Annual Sales Value by Region (US$/GBP Million), 2020
Figure 11-8: Epzicom/Kivexa - Annual Sales Value by Region (%), 2020
Figure 11-9: Global - Epzicom/Kivexa Quarterly Sales Value (US$ Million), 2020
Figure 11-10: US - Triumeq Patent Issue & Expiration Year
Figure 11-11: Epzicom - Price for 30 Tablets Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-12: Global - Triumeq Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-13: US - Triumeq Annual Sales Value by Region (US$/GBP Million), 2020
Figure 11-14: Triumeq - Annual Sales Value by Region (%), 2020
Figure 11-15: Global - Triumeq Quarterly Sales Value (US$/GBP Million), 2020
Figure 11-16: US - Triumeq Quarterly Sales Value (US$/GBP Million), 2020
Figure 11-17: Trizivir - FDA Approval & First Generic Approval
Figure 11-18: Trizivir - Price for 60 Tablets Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-19: Generic Trizivir - Price for 60 Tablets Supply & Price Per Unit of 150mg (US$), February’2021
Figure 11-20: Trizivir - Daily, Monthly & Annual Treatment Cost (US$), February’2021
Figure 11-21: US - Evotaz Patent Issue & Expiration Year
Figure 11-22: Evotaz - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-23: Biktarvy - Gilead’s US Patent Issue & Expiration Year
Figure 11-24: Biktarvy - Emory’s US Patent Issue & Expiration Year
Figure 11-25: Biktarvy - Price for 30 tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-26: Global - Biktarvy Annual Sales Value (US$ Billion), 2018 - 2020
Figure 11-27: Global - Biktarvy Annual Sales Value by Region (US$ Million), 2020
Figure 11-28: Biktarvy - Annual Sales Value by Region (%), 2020
Figure 11-29: Global - Biktarvy Quarterly Sales Value (US$ Million), 2019 - 2020
Figure 11-30: US - Biktarvy Quarterly Sales Value (US$ Million), 2019 - 2020
Figure 11-31: Prezcobix - Gilead’s US Patent Issue & Expiration Year
Figure 11-32: Prezcobix - Tibotic’s US Patent Issue & Expiration Year
Figure 11-33: Prezcobix - Janssen’s US Patent Issue & Expiration Year
Figure 11-34: Prezcobix - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-35: Symtuza - Gilead’s US Patent Issue & Expiration Year
Figure 11-36: Symtuza - Emory’s US Patent Issue & Expiration Year
Figure 11-37: Symtuza - Tibotic’s US Patent Issue & Expiration Year
Figure 11-38: Symtuza - Janssen’s US Patent Issue & Expiration Year
Figure 11-39: Symtuza - Price for 30 tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-40: Dovato - GSK’s US Patent Issue & Expiration Year
Figure 11-41: Dovato - VIIV’s US Patent Issue & Expiration Year
Figure 11-42: Dovato - Price for 30 tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-43: Global - Dovato Annual Sales Value by Region (US$/GBP Million), 2019 &2020
Figure 11-44: US - Dovato Annual Sales Value by Region (US$/GBP Million), 2019 & 2020
Figure 11-45: Dovato - Annual Sales Value by Region (US$/GBP Million), 2020
Figure 11-46: Dovato - Annual Sales Value by Region (%), 2020
Figure 11-47: Global - Dovato Quarterly Sales Value (US$/GBP Million), 2020
Figure 11-48: US - Dovato Quarterly Sales Value (US$/GBP Million), 2020
Figure 11-49: US - Juluca Number of Patent Issued by Assignee Name
Figure 11-50: US - Juluca Patent Expiration Year by Assignee
Figure 11-51: Juluca - Price for 30 tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-52: Global - Juluca Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 11-53: US - Juluca Annual Sales Value (US$/GBP Million), 2017 - 2020
Figure 11-54: Juluca - Annual Sales Value by Region (US$/GBP Million), 2020
Figure 11-55: Juluca - Annual Sales Value by Region (%), 2020
Figure 11-56: Global - Juluca Quarterly Sales Value (US$/GBP Million), 2020
Figure 11-57: US - Juluca Quarterly Sales Value (US$/GBP Million), 2020
Figure 11-58: US - Delstrigo Patent Issue & Expiration Year
Figure 11-59: Delstrigo - Price for 30 tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-60: Delstrigo - Daily, Monthly & Annual Treatment Cost (US$), February’2021
Figure 11-61: Atripla - FDA approval & Generic Approval Year
Figure 11-62: Alripla - Gilead’s US Patent Issue & Expiration Year
Figure 11-63: Atripla - Emory’s US Patent Issue & Expiration Year
Figure 11-64: Atripla - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-65: Generic Atripla - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-66: Global - Atripla Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-67: US - Atripla Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-68: Atripla - Annual Sales Value by Region (US$ Million), 2020
Figure 11-69: Atripla - Annual Sales Value by Region (%), 2020
Figure 11-70: Global - Atripla Quarterly Sales Value (US$ Million), 2020
Figure 11-71: US - Atripla Quarterly Sales Value (US$ Million), 2020
Figure 11-72: Simfi/Simfi Lo - FDA approval Year
Figure 11-73: Simfi/Simfi Lo - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-74: Genvoya - Number of US Patent Issued by Assignee Name
Figure 11-75: Genvoya - US Patent Expiration Year by Assignee
Figure 11-76: Genvoya - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-77: Global - Genvoya Annual Sales Value (US$ Billion), 2017 - 2020
Figure 11-78: US - Genvoya Annual Sales Value (US$ Billion), 2017 - 2020
Figure 11-79: Genvoya - Annual Sales Value by Region (US$ Million), 2020
Figure 11-80: Genvoya - Annual Sales Value by Region (%), 2020
Figure 11-81: Global - Genvoya Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-82: US - Genvoya Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-83: Stribild - Number of US Patent Issued by Assignee Name
Figure 11-84: US - Stribild Patent Expiration Year by Assignee
Figure 11-85: Stribild - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-86: Global - Stribild Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-87: US - Stribild Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-88: Stribild - Annual Sales Value by Region (US$ Million), 2020
Figure 11-89: Stribild - Annual Sales Value by Region (%), 2020
Figure 11-90: Global - Stribild Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-91: US - Stribild Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-92: Odefsey - Number of US Patent Issued by Assignee Name
Figure 11-93: US - Odefsey Patent Expiration Year by Assignee
Figure 11-94: Odefsey - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-95: Global - Odefsey Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-96: Global - Odefsey Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-97: Odefsey - Annual Sales Value by Region (US$ Million), 2020
Figure 11-98: Odefsey - Annual Sales Value by Region (%), 2020
Figure 11-99: Global - Odefsey Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-100: US - Odefsey Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-101: Complera - Number of US Patent Issued by Assignee Name
Figure 11-102: Complera - US Patent Expiration Year by Assignee
Figure 11-103: Complera - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-104: Complera - Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-105: Complera - Annual Sales Value by Region (US$ Million), 2020
Figure 11-106: Complera - Annual Sales Value by Region (%), 2020
Figure 11-107: Global - Complera Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-108: US - Complera Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-109: Descovy - Number of US Patents Issued by Assignee Name
Figure 11-110: Descovy - US Patent Expiration Year by Assignee
Figure 11-111: Descovy - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-112: Descovy - Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-113: Descovy - Annual Sales Value by Region (US$ Million), 2020
Figure 11-114: Descovy - Annual Sales Value by Region (%), 2020
Figure 11-115: Global - Descovy Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-116: US - Descovy Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-117: Truvada - Number of US Patent Issued by Assignee Name
Figure 11-118: US - Descovy Patent Expiration Year by Assignee
Figure 11-119: Truvada: Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-120: Truvada - Annual Sales Value (US$ Million), 2017 - 2020
Figure 11-121: Truvada - Annual Sales Value by Region (US$ Million), 2020
Figure 11-122: Truvada - Annual Sales Value by Region (%), 2020
Figure 11-123: Global - Truvada Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-124: US - Truvada Quarterly Sales Value (US$ Million), 2019 & 2020
Figure 11-125: Cimduo - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-126: Temixys - Price for 30 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-127: Combivir - FDA & First Generic Approval Year
Figure 11-128: Combivir - Price for 60 Tablet Supply & Price Per Unit Tablet (US$), February’2021
Figure 11-129: Generic Combivir - Price for various Supplies of Oral Tablet (US$), February’2021
Figure 11-130: Kaletra - FDA Approval Year by Dosage Form
Figure 11-131: Kaletra Oral Solution - Branded v/s Generic Price for 160 ml Supply & Price Per ml of (US$), February’2021
Figure 11-132: Kaletra Oral Tablet - Price for 60 Tablet & Price per unit Tablets of 100mg-25mg Dose (US$), February’2021
Figure 11-133: Kaletra Oral Tablet - Price for 12 Tablet & 120 Tablet Supply of 200mg-50mg Dose (US$), February’2021
Figure 11-134: Cabenuva - Price for Various Supplies of Cabenuva Suspension Kit (US$), February’2021
Figure 11-135: Cabenuva - Recommended Initial & Subsequent Dose (mg/Month),
Figure 11-136: Emtricitabine / Nelfinavir / Tenofovir Oral Kit - Price Per Unit by Product (US$), February’2021
Figure 11-137: Emtricitabine / Nelfinavir / Tenofovir Oral Kit - Price Per Unit by Product (US$), February’2021"
